Dr. Hassan Dakroub, M.D

Internal Medicine Dearborn, MI Male
NPI: 1528099397
Total Payments
$14,081
2024 Payments
$2,372
Companies
45
Transactions
837
Medicare Patients
3,198
Medicare Billing
$420,615

Payment Breakdown by Category

Food & Beverage$13,085 (92.9%)
Education$995.88 (7.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,085 815 92.9%
Education $995.88 22 7.1%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $4,089 247 $0 (2024)
ViiV Healthcare Company $1,799 131 $0 (2024)
ABBVIE INC. $1,650 102 $0 (2024)
Merck Sharp & Dohme LLC $899.74 65 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $670.15 39 $0 (2024)
AstraZeneca Pharmaceuticals LP $637.27 44 $0 (2024)
Janssen Products, LP $522.92 6 $0 (2021)
Janssen Biotech, Inc. $505.42 35 $0 (2023)
Astellas Pharma US Inc $486.71 11 $0 (2023)
Lilly USA, LLC $299.09 20 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,372 126 Gilead Sciences, Inc. ($965.03)
2023 $2,382 120 Gilead Sciences, Inc. ($871.32)
2022 $2,205 142 Gilead Sciences, Inc. ($664.02)
2021 $2,192 132 Gilead Sciences, Inc. ($588.85)
2020 $1,145 72 Gilead Sciences, Inc. ($239.87)
2019 $1,266 76 Gilead Sciences, Inc. ($387.86)
2018 $1,085 83 Gilead Sciences, Inc. ($246.76)
2017 $1,434 86 Astellas Pharma US Inc ($292.28)

All Payment Transactions

837 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
12/20/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $21.77 General
Category: VIROLOGY
12/17/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $20.19 General
12/16/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $22.94 General
Category: Otolaryngology (Ear, Nose, Throat)
12/13/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $21.55 General
Category: INFECTIOUS DISEASE
12/12/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $20.47 General
Category: HIV
12/09/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $21.09 General
12/06/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $19.16 General
12/05/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $20.26 General
Category: Inflammation/Rare Disease
11/25/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $23.47 General
Category: ANTIBIOTIC
11/21/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $18.88 General
11/19/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $14.21 General
11/19/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $8.72 General
Category: HIV
11/18/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $24.32 General
Category: VIROLOGY
11/12/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $14.27 General
Category: HIV
11/12/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $7.74 General
11/11/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $23.60 General
11/07/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.13 General
Category: Diabetes
11/04/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $20.26 General
Category: Otolaryngology (Ear, Nose, Throat)
10/31/2024 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $23.26 General
Category: COVID-19
10/29/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $19.66 General
10/28/2024 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $21.24 General
Category: ANTIBIOTIC
10/25/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $20.29 General
10/24/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $28.99 General
10/22/2024 Novo Nordisk Inc — Food and Beverage In-kind items and services $19.95 General
10/22/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $13.80 General
Category: HIV
123…34»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 595 1,062 $208,816 $80,333
2022 4 745 1,199 $248,851 $94,179
2021 12 1,064 1,949 $319,532 $132,857
2020 8 794 1,648 $296,387 $113,245
Total Patients
3,198
Total Services
5,858
Medicare Billing
$420,615
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 290 327 $98,100 $33,613 34.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 178 365 $54,750 $22,732 41.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 74 292 $43,746 $18,500 42.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 40 58 $11,420 $5,279 46.2%
96372 Injection of drug or substance under skin or into muscle Office 2023 13 20 $800.00 $208.44 26.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 394 453 $135,900 $48,609 35.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 264 569 $85,350 $32,826 38.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 61 145 $21,261 $9,423 44.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 26 32 $6,340 $3,322 52.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 301 886 $132,900 $52,237 39.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 314 346 $103,800 $38,525 37.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 90 311 $46,324 $20,267 43.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 64 107 $21,400 $9,626 45.0%
0002A Adm sarscov2 30mcg/0.3ml 2nd Office 2021 54 54 $2,160 $2,160 100.0%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 23 23 $4,540 $1,975 43.5%
0001A Adm sarscov2 30mcg/0.3ml 1st Office 2021 47 49 $1,960 $1,960 100.0%
0012A Adm sarscov2 100mcg/0.5ml2nd Office 2021 54 54 $1,797 $1,797 100.0%
0064A Fee covid-19 vac 7 res Office 2021 40 40 $1,600 $1,600 100.0%
0004A Fee covid-19 vac 1 res Office 2021 36 36 $1,440 $1,440 100.0%
0011A Adm sarscov2 100mcg/0.5ml1st Office 2021 30 30 $1,131 $1,131 100.0%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 11 13 $480.00 $139.20 29.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 260 705 $105,750 $42,235 39.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 300 328 $98,400 $37,776 38.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 106 382 $55,128 $19,559 35.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 77 158 $31,600 $11,503 36.4%
12»

About Dr. Hassan Dakroub, M.D

Dr. Hassan Dakroub, M.D is a Internal Medicine healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528099397.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hassan Dakroub, M.D has received a total of $14,081 in payments from pharmaceutical and medical device companies, with $2,372 received in 2024. These payments were reported across 837 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($13,085).

As a Medicare-enrolled provider, Dakroub has provided services to 3,198 Medicare beneficiaries, totaling 5,858 services with total Medicare billing of $420,615. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Infectious Disease
  • Location Dearborn, MI
  • Active Since 07/06/2006
  • Last Updated 11/07/2019
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1528099397

Products in Payments

  • CABENUVA (Biological) $860.90
  • MAVYRET (Drug) $733.14
  • JARDIANCE (Drug) $533.27
  • DOVATO (Drug) $495.09
  • SYMTUZA (Drug) $488.64
  • APRETUDE (Biological) $352.87
  • Symtuza (Drug) $255.41
  • PREZCOBIX (Drug) $254.49
  • FARXIGA (Drug) $226.38
  • PIFELTRO (Drug) $224.96
  • ZERBAXA (Drug) $220.80
  • VRAYLAR (Drug) $195.26
  • ISENTRESS (Drug) $184.32
  • SYMBICORT (Drug) $163.30
  • XARELTO (Drug) $140.39
  • Mavyret (Drug) $139.84
  • BREZTRI (Drug) $135.44
  • LINZESS (Drug) $134.39
  • Vascepa (Drug) $134.38
  • ELIQUIS (Drug) $125.00

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Dearborn

Wassim Younes, Md, Rph, MD, RPH

Internal Medicine — Payments: $215,063

Internal Medicine $215,063

Abdulhassan Saad, M.d, M.D

Internal Medicine — Payments: $199,745

Internal Medicine $199,745

Ziad Berri, Md, MD

Internal Medicine — Payments: $47,432

Internal Medicine $47,432

Dr. Opada Alzohaili, Md, MD

Internal Medicine — Payments: $39,452

Internal Medicine $39,452

Mohamad Khansa

Internal Medicine — Payments: $36,417

Internal Medicine $36,417

Dr. Mazen Elatrache, Md, MD

Internal Medicine — Payments: $28,467

Internal Medicine $28,467